Suggestions
Michael Langer
Co-Founder and Managing Partner at T.Rx Capital
Michael Langer is a prominent figure in the life sciences and healthcare investment industry with a diverse background in venture capital, corporate development, and entrepreneurship. Here's an overview of his career and accomplishments:
Career at Pear Therapeutics
Michael Langer held several positions at Pear Therapeutics, a company that develops clinically-validated software-based therapeutics. His roles included:
- Director and Head of Search, Evaluation, In-Licensing, Corporate Development (January 2023)
- Associate Director and Head of Search, Evaluation and In-licensing, Corporate Development (January 2022 - January 2023)
- Senior Manager and Head of Search, Evaluation & In-Licensing, Corporate Development (January 2021 - January 2022)
- Manager and Search and Evaluation Lead, Corporate Development (January 2020 - January 2021)
- Senior Associate, Corporate Development (January 2019 - January 2020)
- Associate, Corporate Development (March 2018 - January 2019)
- Analyst, Corporate Development (November 2017 - March 2018)
During his time at Pear Therapeutics, Michael led or co-led 15 different transactions and was responsible for running the company's Search, Evaluation, and In-licensing function.12
Current Ventures
Michael is currently involved in several ventures:
- Co-founder & Managing Partner at T.Rx Capital: A venture capital firm focused on investing at the intersection of technology and biology, specializing in company creation, seed, and Series A investments.3
- Investor and Board Observer at Zus Health (March 2023 - Present).3
- Advisory Board Member for Startups Category at The Galien Foundation (January 2023 - Present).3
Previous Investments and Entrepreneurship
Prior to his current roles, Michael:
- Founded Old Silver VC, a family investment firm focusing on healthcare and deep tech startups.12
- Invested in over 20 companies, including Big Hat Biosciences, Sesame Care, Seismic Therapeutics, Alto Pharmacy, and Opentrons.12
Education and Early Career
Michael holds a BA from Lehigh University in Science, Technology and Society with a Double Minor in Entrepreneurship and Sustainable Development.2 He has also spent time at several startups and venture capital funds, including Akili Interactive Labs, Udacity, Modern Meadow, Polaris Partners, and Boston Seed Capital.2
Philanthropy and Leadership
Michael is actively involved in various philanthropic and leadership roles:
- Co-founder of the Young Coder's Society, teaching children how to code using Raspberry Pi.12
- Serves on the Leadership Board at Beth Israel Deaconess Medical Center.12
- Member of the Global Board of Directors for MassChallenge.2
- Senior Advisor of Special Projects at the Galenus Foundation.12
- Former Young Leader at the Milken Institute and World Economic Forum Global Shaper.12
Michael Langer's career demonstrates a strong commitment to innovation in healthcare and technology, coupled with a dedication to philanthropy and mentorship in the startup ecosystem.
Highlights
The Guardian once referred to my father as the Willy Wonka of the biotech industry for his work at the Massachusetts Institute of Technology in creating longer lasting medicine or unique drug delivery mechanisms. To honor those accomplishments and his lifelong love for chocolate, we are excited to announce “Dr. Bob's Dark Chocolate Maple Cream” with Ben & Bill’s Chocolate Emporium in Falmouth, MA.
Ben & Bill’s is a local favorite for people who go to the Cape and we have been going for nearly 30 years. This story was written up by the Boston Globe Media and Jon Chesto this week and It was a joy to see my father in his element — surrounded by family, celebrating both this delicious new treat and the incredible small business he’s supported for years. The whole family came together in Falmouth to mark the occasion, and it’s a memory we’ll treasure for a long time.
Ben & Bill’s took their homemade maple center cream dipped in semi-sweet dark chocolate and added a drizzel of their favorite maple sryups to the top. The addition of this extra burst of maple flavor really sends it over the top, it is epic.
If you find yourself in Falmouth and you’re a fan of sweets (or just curious to try the latest creation), I can’t recommend Ben & Bill’s enough. You can also check it out online. A huge thank you to their amazing team for recognizing my dad with this unique and meaningful honor — it’s been such a wonderful way to celebrate both his birthday and his enduring passion for chocolate!
Click here if you want to try them! https://lnkd.in/eN9PKwS2
Guardian article: https://lnkd.in/eG47QB9E
https://lnkd.in/ebA_HQVg
Congratulations to Moderna for securing FDA approval for their RSV vaccine, mRESVIA. This is a huge step forward in combating RSV, which is a major cause of respiratory illness in older adults. The approval demonstrates the ways that new technologies, like mRNA, are redefining human health.
In a 37,000 person study, mRESVIA had an impressive efficacy of 83.7%. It's also the only RSV vaccine available in single-dose pre-filled syringes, making administration simpler and reducing clinical errors.
This achievement highlights Moderna’s dedication to innovation and expanding mRNA technology beyond COVID-19. Their recent partnership with OpenAI is another example of how they're pushing the boundaries of pharma and revolutionizing healthcare.
This success promises a brighter future for public health, with the vaccine available for the 2024/2025 season. Here’s to the marriage of technology and biology to improve patient’s lives!
